Dr Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases and the US President's chief medical adviser, has said that he believes the AstraZeneca (LON:AZN) COVID-19 vaccine should be accepted by the US under its new travel rules, BBC News reported on Tuesday.
Currently, the US regulator does not recommend the AstraZeneca vaccine for use in the US.
However Dr Fauci said he knows there is a lot of data available on the vaccine.
Dr Fauci told BBC Radio 4's Today programme that given the fact the situation in the US is comparable with so many other countries, including the UK, the government wants to have a uniform policy of requiring vaccinations and testing.
Also, Dr Fauci added that the sooner the world gets vaccinated the "greater the chance we will get of not allowing variants to emerge".
According to Dr Fauci, it is less to do with travel and more to do with getting everyone vaccinated.
CSL's ANDEMBRY receives European approval to prevent attacks of hereditary angioedema
NICE recommends ALK's ACARIZAX for house dust mite allergic rhinitis treatment in UK's NHS
European Commission approves Palforzia for toddlers with peanut allergy
Eli Lilly and Co receives approval from FDA for Zepbound
CSL gains EMA backing for Garadacimab as HAE prophylactic treatment
Merck initiates Phase 3 trial for LAGEVRIO (molnupiravir)
Allergy Therapeutics reports positive data from VLP Peanut PROTECT trial
CBC Group acquires UCB's mature neurology and allergy business in China
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children